Search

Your search keyword '"Wendt, Camilla"' showing total 300 results

Search Constraints

Start Over You searched for: Author "Wendt, Camilla" Remove constraint Author: "Wendt, Camilla"
300 results on '"Wendt, Camilla"'

Search Results

1. Incorporating progesterone receptor expression into the PREDICT breast prognostic model

2. Aggregation tests identify new gene associations with breast cancer in populations with diverse ancestry

3. Gene-Environment Interactions Relevant to Estrogen and Risk of Breast Cancer: Can Gene-Environment Interactions Be Detected Only among Candidate SNPs from Genome-Wide Association Studies?

4. The impact of coding germline variants on contralateral breast cancer risk and survival

5. Swedish Genome-Wide Haplotype Association Analysis Suggests Breast Cancer Loci with Varying Risk-Modifying Effects.

6. Rare germline copy number variants (CNVs) and breast cancer risk

7. Common variants in breast cancer risk loci predispose to distinct tumor subtypes

8. Preference for the fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection in patients with HER2-positive early breast cancer (PHranceSCa): A randomised, open-label phase II study

9. Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element

10. PHIP - a novel candidate breast cancer susceptibility locus on 6q14.1

11. Mendelian randomisation study of smoking exposure in relation to breast cancer risk

12. Prediction of contralateral breast cancer: external validation of risk calculators in 20 international cohorts

13. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

14. A search for modifying genetic factors in CHEK2:c.1100delC breast cancer patients

15. The association between weight at birth and breast cancer risk revisited using Mendelian randomisation

16. Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes

17. Co-observation of germline pathogenic variants in breast cancer predisposition genes: Results from analysis of the BRIDGES sequencing dataset

18. Genome-wide association study of germline variants and breast cancer-specific mortality

19. A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer

20. Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survival

21. Prediction and clinical utility of a contralateral breast cancer risk model

22. Two truncating variants in FANCC and breast cancer risk

23. Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer

24. A Swedish Familial Genome-Wide Haplotype Analysis Identified Five Novel Breast Cancer Susceptibility Loci on 9p24.3, 11q22.3, 15q11.2, 16q24.1 and Xq21.31

25. Aggregation tests identify new gene associations with breast cancer in populations with diverse ancestry

26. The impact of coding germline variants on contralateral breast cancer risk and survival

28. Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survival

29. Association analysis identifies 65 new breast cancer risk loci

30. Incorporating progesterone receptor expression into the PREDICT breast prognostic model

31. A Swedish Genome-Wide Haplotype Association Analysis Identifies a Novel Breast Cancer Susceptibility Locus in 8p21.2 and Characterizes Three Loci on Chromosomes 10, 11 and 16

32. Additional file 4 of Common variants in breast cancer risk loci predispose to distinct tumor subtypes

33. A Swedish Genome-Wide Haplotype Association Analysis Identifies a Novel Breast Cancer Susceptibility Locus in 8p21.2 and Characterizes Three Loci on Chromosomes 10, 11 and 16

34. Mendelian randomisation study of smoking exposure in relation to breast cancer risk

35. CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers

36. Preference for the fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection in patients with HER2-positive early breast cancer (PHranceSCa): A randomised, open-label phase II study

37. Rare Copy Number Variants (CNVs) and Breast Cancer Risk

38. Transcriptome‐wide association study of breast cancer risk by estrogen‐receptor status

39. Author Correction : A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.

40. Gene-environment interactions relevant to estrogen and risk of breast cancer:Can gene-environment interactions be detected only among candidate snps from genome-wide association studies?

41. Evaluation of European-based polygenic risk score for breast cancer in Ashkenazi Jewish women in Israel

42. Common breast cancer risk loci predispose to distinct tumor subtypes

43. Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes

44. Prediction of contralateral breast cancer:external validation of risk calculators in 20 international cohorts

45. Tumour spectrum in non-BRCA hereditary breast cancer families in Sweden

46. Fine-mapping of 150 breast cancer risk regions identifies 178 high confidence target genes

47. MOESM3 of Prediction and clinical utility of a contralateral breast cancer risk model

48. Associations of obesity and circulating insulin and glucose with breast cancer risk : a Mendelian randomization analysis

49. The FANCM :p.Arg658* truncating variant is associated with risk of triple-negative breast cancer

50. The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer

Catalog

Books, media, physical & digital resources